The role of tumor budding (single tumor cells and small groups of tumor cells) is associated with a lack of response to NAT and a poor outcome in general as tumor buds are considered to be a feature of epithelial-mesenchymal transition and it is associated with the mesenchymal subtype. The gene discussed is BRD2; the disease is neoplasm.